Online citations, reference lists, and bibliographies.

Real-time Fluorescence Imaging Of Abdominal, Pleural, And Lymphatic Metastases.

S. Carpenter, Y. Fong
Published 2012 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Virally-directed fluorescence imaging has the potential to revolutionize intra-operative oncologic staging and tumor resection. Many viruses genetically engineered to specifically infect tumor cells as cancer therapy can be further modified to have a visible marker gene for cancer staging. In this chapter, we describe such a herpes simplex virus (HSV) modified to be detected by fluorescence. Other viruses so designed can be similarly used in cancer detection and staging. Replication-competent, tumor-specific HSV NV1066 expresses green fluorescent protein (GFP) in infected cancer cells. One single dose of NV1066 administered via intratumor, intracavitary, or systemic injection can spread within and across body cavities to target tumor cells while sparing normal tissue cells from infection. Tumors otherwise invisible by conventional laparoscopy appear green with the use of an endoscope equipped with a fluorescent filter. Furthermore, with GFP expression easily visualized by stereomicroscopy, microscopic, and pathologic analysis is significantly enhanced. This chapter addresses NV1066-directed visualization of peritoneal, pleural, and lymphatic metastases. This chapter also provides protocols for the production of tumor models in various body cavities in rodents.
This paper references
Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
P. Sugarbaker (2001)
Lymphatic mapping and sentinel lymphadenectomy for breast cancer.
M. Kelley (2004)
Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses
P. McAuliffe (2000)
The Role of Staging Laparoscopy in Hepatobiliary Malignancy: Prospective Analysis of 401 Cases
M. D'angelica (2003)
Long-Term Survival of Peritoneal Carcinomatosis of Colorectal Origin
V. Verwaal (2004)
Managing the peritoneal surface component of gastrointestinal cancer. Part 1. Patterns of dissemination and treatment options.
P. Sugarbaker (2004)
Effective therapy for peritoneal dissemination in gastric cancer.
Y. Yonemura (2003)
Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus.
R. Wong (2001)
Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma.
C. Corvera (2005)
Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.
V. Rusch (1999)
Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer
J. Bennett (2002)
Improving diagnostic staging laparoscopy using intraperitoneal lavage of delta-aminolevulinic acid (ALA) for laparoscopic fluorescence diagnosis.
J. Gahlen (1999)
Laparoscopy for Malignancy: Current Status
P. Paraskeva (2004)
Green fluorescent protein as a marker for gene expression.
M. Chalfie (1994)
Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection.
U. Veronesi (2005)
Virally directed fluorescent imaging improves diagnostic sensitivity in the detection of minimal residual disease after potentially curative cytoreductive surgery
P. Adusumilli (2005)
Treatment of Malignant Mesothelioma
M. Jaklitsch (2001)
Indications for pneumonectomy. Extrapleural pneumonectomy.
V. Rusch (1999)
A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases
W. Jarnagin (2001)
Infection with Oncolytic Herpes Simplex Virus-1 Induces Apoptosis in Neighboring Human Cancer Cells
S. F. Stanziale (2004)
Real‐time diagnostic imaging of tumors and metastases by use of a replication‐competent herpes vector to facilitate minimally invasive oncological surgery
P. Adusumilli (2006)
Herpes viral oncolysis: a novel cancer therapy.
M. Reinblatt (2007)
Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases.
R. Wong (2002)
Virally-directed fluorescent imaging (VFI) can facilitate endoscopic staging
P. Adusumilli (2005)
Managing the peritoneal surface component of gastrointestinal cancer. Part 2. Perioperative intraperitoneal chemotherapy.
P. Sugarbaker (2004)
Intraoperative localization of lymph node metastases with a replication-competent herpes simplex virus.
P. Adusumilli (2006)
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
T. Liu (2007)
Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology.
X. Jiao (2002)
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
V. Rusch (2001)
Oncolytic herpes simplex virus-1 mutant expressing green fluorescent protein can detect and treat peritoneal cancer.
S. F. Stanziale (2004)
The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer.
B. Stiles (2003)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar